Jadenu
Active Ingredient(s): DeferasiroxFDA Approved: * March 30, 2015
Pharm Company: * NOVARTIS PHARMS CORP
Category: Iron Chelator
Deferasirox, sold under the brand name Exjade & Asunra (in injectable form) & Oleptiss (Tablet formulation) both by Novartis among others, is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.[2][3] It is the first oral medication approved in the United States for this purpose.[4] It was appro... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.